Literature DB >> 32094299

A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.

Hernando Lopez-Bertoni1,2, Ivan S Kotchetkov3, Nicole Mihelson4, Bachchu Lal5,2, Yuan Rui6, Heather Ames7, Maria Lugo-Fagundo5, Hugo Guerrero-Cazares8,9, Alfredo Quiñones-Hinojosa8,9, Jordan J Green6,8,10,11,12, John Laterra1,2,11,13.   

Abstract

Glioblastoma multiforme (GBM) and other solid malignancies are heterogeneous and contain subpopulations of tumor cells that exhibit stem-like features. Our recent findings point to a dedifferentiation mechanism by which reprogramming transcription factors Oct4 and Sox2 drive the stem-like phenotype in glioblastoma, in part, by differentially regulating subsets of miRNAs. Currently, the molecular mechanisms by which reprogramming transcription factors and miRNAs coordinate cancer stem cell tumor-propagating capacity are unclear. In this study, we identified miR-486-5p as a Sox2-induced miRNA that targets the tumor suppressor genes PTEN and FoxO1 and regulates the GBM stem-like cells. miR-486-5p associated with the GBM stem cell phenotype and Sox2 expression and was directly induced by Sox2 in glioma cell lines and patient-derived neurospheres. Forced expression of miR-486-5p enhanced the self-renewal capacity of GBM neurospheres, and inhibition of endogenous miR-486-5p activated PTEN and FoxO1 and induced cell death by upregulating proapoptotic protein BIM via a PTEN-dependent mechanism. Furthermore, delivery of miR-486-5p antagomirs to preestablished orthotopic GBM neurosphere-derived xenografts using advanced nanoparticle formulations reduced tumor sizes in vivo and enhanced the cytotoxic response to ionizing radiation. These results define a previously unrecognized and therapeutically targetable Sox2:miR-486-5p axis that enhances the survival of GBM stem cells by repressing tumor suppressor pathways. SIGNIFICANCE: This study identifies a novel axis that links core transcriptional drivers of cancer cell stemness to miR-486-5p-dependent modulation of tumor suppressor genes that feeds back to regulate glioma stem cell survival. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32094299      PMCID: PMC7165043          DOI: 10.1158/0008-5472.CAN-19-1624

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  Regulation of miR-23b expression and its dual role on ROS production and tumour development.

Authors:  Massimo Donadelli; Ilaria Dando; Claudia Fiorini; Marta Palmieri
Journal:  Cancer Lett       Date:  2014-04-19       Impact factor: 8.679

2.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

3.  SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Authors:  Rosaria Maria Rita Gangemi; Fabrizio Griffero; Daniela Marubbi; Marzia Perera; Maria Cristina Capra; Paolo Malatesta; Gian Luigi Ravetti; Gian Luigi Zona; Antonio Daga; Giorgio Corte
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

4.  PTEN-regulated AKT/FoxO3a/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate.

Authors:  Sonia Aroui; Lucie Dardevet; Feten Najlaoui; Meriem Kammoun; Amel Laajimi; Hamadi Fetoui; Michel De Waard; Abderraouf Kenani
Journal:  Int J Biochem Cell Biol       Date:  2016-05-19       Impact factor: 5.085

5.  Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.

Authors:  H Lopez-Bertoni; B Lal; N Michelson; H Guerrero-Cázares; A Quiñones-Hinojosa; Y Li; J Laterra
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

6.  Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.

Authors:  Chongmin Ren; Tingting Ren; Kang Yang; Shidong Wang; Xing Bao; Fan Zhang; Wei Guo
Journal:  J Exp Clin Cancer Res       Date:  2016-03-11

Review 7.  BCL-2 family proteins: changing partners in the dance towards death.

Authors:  Justin Kale; Elizabeth J Osterlund; David W Andrews
Journal:  Cell Death Differ       Date:  2017-11-17       Impact factor: 15.828

8.  Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.

Authors:  Yang Shao; Yu-Qing Shen; Yan-Li Li; Chen Liang; Bing-Jie Zhang; Sheng-Di Lu; Yan-Yun He; Ping Wang; Qiang-Ling Sun; You-Xin Jin; Zhong-Liang Ma
Journal:  Oncotarget       Date:  2016-06-07

9.  miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.

Authors:  Baoping Lang; Song Zhao
Journal:  Oncol Rep       Date:  2017-11-01       Impact factor: 3.906

10.  The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways.

Authors:  Yang Yang; Changwei Ji; Suhan Guo; Xin Su; Xiaozhi Zhao; Shiwei Zhang; Guangxiang Liu; Xuefeng Qiu; Qing Zhang; Hongqian Guo; Huimei Chen
Journal:  Oncotarget       Date:  2017-08-24
View more
  11 in total

1.  Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.

Authors:  Jayoung Kim; Sujan K Mondal; Stephany Y Tzeng; Yuan Rui; Rawan Al-Kharboosh; Kristen K Kozielski; Adip G Bhargav; Cesar A Garcia; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  ACS Biomater Sci Eng       Date:  2020-04-17

2.  miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection.

Authors:  Yihua Bei; Dongchao Lu; Christian Bär; Shambhabi Chatterjee; Alessia Costa; Isabelle Riedel; Frank C Mooren; Yujiao Zhu; Zhenzhen Huang; Meng Wei; Meiyu Hu; Sunyi Liu; Pujiao Yu; Kun Wang; Thomas Thum; Junjie Xiao
Journal:  Mol Ther       Date:  2022-01-22       Impact factor: 12.910

3.  Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.

Authors:  Alexander Fichte; Angela Neumann; Katrin Weigelt; Juan Guzman; Thilo Jansen; Julia Keinert; Ginette Serrero; Binbin Yue; Robert Stöhr; Thomas Greither; Arndt Hartmann; Bernd Wullich; Helge Taubert; Sven Wach; Verena Lieb
Journal:  Life (Basel)       Date:  2022-05-13

4.  circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.

Authors:  Yao Kong; Yuting Li; Yuming Luo; Jiang Zhu; Hanhao Zheng; Bowen Gao; Xiaofeng Guo; Zhihua Li; Rufu Chen; Changhao Chen
Journal:  Mol Cancer       Date:  2020-05-04       Impact factor: 27.401

5.  Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.

Authors:  Hernando Lopez-Bertoni; Amanda Johnson; Yuan Rui; Bachchu Lal; Sophie Sall; Maureen Malloy; Jonathan B Coulter; Maria Lugo-Fagundo; Sweta Shudir; Harmon Khela; Christopher Caputo; Jordan J Green; John Laterra
Journal:  Signal Transduct Target Ther       Date:  2022-02-09

6.  The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.

Authors:  Jinguan Lin; Longzheng Xia; Linda Oyang; Jiaxin Liang; Shiming Tan; Nayiyuan Wu; Pin Yi; Qing Pan; Shan Rao; Yaqian Han; Yanyan Tang; Min Su; Xia Luo; Yiqing Yang; Xiaohui Chen; Lixia Yang; Yujuan Zhou; Qianjin Liao
Journal:  Oncogene       Date:  2022-01-08       Impact factor: 9.867

Review 7.  Interplay of SOX transcription factors and microRNAs in the brain under physiological and pathological conditions.

Authors:  Milena Stevanovic; Danijela Stanisavljevic Ninkovic; Marija Mojsin; Danijela Drakulic; Marija Schwirtlich
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 8.  Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses.

Authors:  Sakhawat Ali; Qin Xia; Tahir Muhammad; Liqun Liu; Xinyi Meng; David Bars-Cortina; Aamir Ali Khan; Yinghui Huang; Lei Dong
Journal:  Stem Cell Rev Rep       Date:  2021-07-28       Impact factor: 5.739

Review 9.  Safety considerations for nanoparticle gene delivery in pediatric brain tumors.

Authors:  Kathryn M Luly; John Choi; Yuan Rui; Jordan J Green; Eric M Jackson
Journal:  Nanomedicine (Lond)       Date:  2020-07-23       Impact factor: 6.096

Review 10.  Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.

Authors:  Rohit K Sharma; Carlos Calderon; Pablo E Vivas-Mejia
Journal:  Front Med Technol       Date:  2021-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.